Skip to toolbar

“One of the ways to improve cancer care is to ensure that no regions are lagging behind. We also need to focus on Māori to ensure there’s equity in access and care.” Professor John Windsor.

A debilitating and notoriously hard-to-beat disease, pancreatic cancer can go undetected for a long time and by the time a patient presents with symptoms it is often too late. With a 5% survival rate, patient outcomes to date have largely been dismal. However, it is not all grim news. Genomics research, showing gene differences specific to pancreatic cancer, has identified sub-groups with better outcomes upon targeted and more-effective chemotherapy drugs administered as first-line of treatment.

We acknowledge there is room for improvement in the care of pancreatic cancer in New Zealand – “a need addressed by The Ministry of Health in its establishment of the Te Aho O Te Kahu – Cancer Control Agency (CCA), led by Professor Diana Sarfati, with improvement in care being one of its key focuses”.

STaR Centre is collaborating with Te Aho O Te Kahu – Cancer Control Agency (CCA) to on a project to develop quality performance indicators (QPI) for pancreatic cancer.

Read more about this here: https://www.auckland.ac.nz/en/news/2020/11/02/pancreatic-cancer-treatment-john-windsor.html